Levels of X-linked inhibitor of apoptosis protein and survivin in pleural effusion and bronchoalveolar lavage fluid in early diagnosis of lung cancer

Clinical Focus ›› 2012, Vol. 27 ›› Issue (12): 1021-1024.

Previous Articles Next Articles

Levels of X-linked inhibitor of apoptosis protein and survivin in pleural effusion and bronchoalveolar lavage fluid in early diagnosis of lung cancer

ZHANG Juan-li;YUE Hong-mei;NI Zhi-hong

Online:2012-06-20 Published:2012-06-20

Abstract

CLC Number:

R734.2

ZHANG Juan-li;YUE Hong-mei;NI Zhi-hong. Levels of X-linked inhibitor of apoptosis protein and survivin in pleural effusion and bronchoalveolar lavage fluid in early diagnosis of lung cancer[J]. Clinical Focus, 2012, 27(12): 1021-1024.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2012/V27/I12/1021

[1]	Li Shufan, Wang Yuxiu, Jiang Zhenghua. The correlation between the prognosis of lung adenocarcinoma with acquired resistance to the first-generation EGFR TKI and the T790M mutation [J]. Clinical Focus, 2022, 37(11): 985-991.
[2]	Huang Ping, Liu Hanyun, Li Yuhong. Risk factors of lung cancer with pulmonary embolism:a meta-analysis [J]. Clinical Focus, 2021, 36(12): 1061-1066.
[3]	. [J]. Clinical Focus, 2021, 36(12): 1132-1135.
[4]	Li Guanzhu, Lai Yuan, Zheng Xiaozhuo, Jiang Ran, Wei Ke. Effects of goal-directed fluid therapy on intraoperative balance between oxygen delivery and consumption and postoperative outcomes in thoracic surgery patients: a meta-analysis [J]. Clinical Focus, 2021, 36(8): 677-684.
[5]	Xu Ying, Han Caijuan, Fan Hong, Meng Zerong, Wang Xiaojun, Liu Hua. Relationship between long non-coding RNA overexpression and poor prognostic of small cell lung cancer: a meta-analysis [J]. Clinical Focus, 2021, 36(8): 685-690.
[6]	Wang Ai. Effects of Kangai injection combined with bevacizumab and DP scheme on efficacy and serum tumor markers and prognosis of NSCLC [J]. Clinical Focus, 2021, 36(6): 517-521.
[7]	Yang Ke, Chen Jun. Value of serum NSE, CEA and CA125 levels in diagnosis and efficacy evaluation of patients with small cell lung cancer [J]. Clinical Focus, 2021, 36(3): 225-228.
[8]	Liu Xinyan,Wei Hongyan, Dai Xianli, Liu Ying. Clinical efficacy of chemotherapy combined with location intervened by bronchoscope in central lung cancer [J]. Clinical Focus, 2016, 31(4): 389-391.
[9]	Li Yajie;Chen Kai. Analysis of transbronchial needle aspiration in 224 cases with mediastinal lymphadenectasis [J]. Clinical Focus, 2015, 30(10): 1159-1162.
[10]	. @@ [J]. Clinical Focus, 2015, 30(10): 1197-1200.
[11]	Chi Hongwei;Wang Canghai;Yang Zhiming;Ren Jinjun;Xu Qian;Chen Yanfang. Appilcation of apparent diffusion coefficient value in chemotherapy efficacy evaluation on non-small cell lung carcinoma [J]. Clinical Focus, 2015, 30(8): 883-887.
[12]	Du Junhua;Yin Yifa;Qiao Hongyuan. Effect of maintenance therapy with Huisheng Oral Liquid for patients in mid-advanced non-small cell lung cancer [J]. Clinical Focus, 2015, 30(6): 641-644.
[13]	Hu Shanshan;Zhang Shun;Cai Ting. Immunochemotherapy for advanced non-small cell lung cancer:a meta-analysis [J]. Clinical Focus, 2015, 30(3): 283-289.
[14]	Li Long;Tang Fabing;Yu Qin. Expression of EGFR and RAS/MAPK signal pathway-related proteins and their significance in lung adenocarcinoma [J]. Clinical Focus, 2015, 30(3): 290-292296.
[15]	Chen Yunping;Li Jiancheng;Zhang Jiangling;Hong Chaoxin;Luo Danfeng;Lai Zhangchao. Clinical effect of intensity modulated radiation therapy for treatment of local medium and advanced non-small cell lung cancer [J]. Clinical Focus, 2015, 30(1): 48-5051.

Levels of X-linked inhibitor of apoptosis protein and survivin in pleural effusion and bronchoalveolar lavage fluid in early diagnosis of lung cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments